Knowledge Center

Patent / Jan 01, 1973

16.beta.-Methyl-17.alpha.-hydroxypregna-1,4,9(11)-triene-3,20-dione

Authors:
  • Ivan Villax
Source:
US 3761498

Pregnatrienedione I was prepd. from pregnanone II by KBH4 redn. followed by successive dehydration, methylation, bromination, and debromination.

Also in the Knowledge Center

Related Content

Speak Up!

An Ethics Line to enable team members to Speak Up!

Page
Read more

Dispersome®

Make your drug soluble with Dispersome® technology. Dispersome® is a solubility enhancement technology that relies on an innovative and naturally occurring excipient to develop amorphous solid dispersions with high drug loading and high bioavailability.

Page
Read more

Nanoparticles

At Hovione we have both top-down and bottom-up technologies to produce pharmaceutical nanoparticles for oral delivery.

Page
Read more